131 related articles for article (PubMed ID: 6167711)
1. Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine.
Fuller RW; Snoddy HD; Mason NR; Hemrick-Luecke SK; Clemens JA
J Pharmacol Exp Ther; 1981 Sep; 218(3):636-41. PubMed ID: 6167711
[No Abstract] [Full Text] [Related]
2. The influence of quipazine on the turnover rate of serotonin.
Grabowska M; Antkiewicz L; Michaluk J
Biochem Pharmacol; 1974 Nov; 23(22):3211-2. PubMed ID: 4441411
[No Abstract] [Full Text] [Related]
3. [Quipazine antagonizing baclofen activity. Influence of baclofen and gamma-hydroxybutyric acid on serotonin metabolism in rat brain (author's transl)].
Waldmeier PC; Maître L
Arzneimittelforschung; 1978; 28(9):1507-8. PubMed ID: 582544
[TBL] [Abstract][Full Text] [Related]
4. The effects of quipazine on serotonin metabolism in rat brain.
Fuller RW; Snoddy HD; Perry KW; Roush BW; Molloy BB; Bymaster FP; Wong DT
Life Sci; 1976 May; 18(9):925-33. PubMed ID: 1271962
[No Abstract] [Full Text] [Related]
5. The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations.
Jacoby JH; Poulakos JJ
J Pharm Pharmacol; 1977 Dec; 29(12):771-3. PubMed ID: 22629
[No Abstract] [Full Text] [Related]
6. 1-(1-Naphthyl)piperazine, a central serotonin agonist.
Fuller RW; Mason NR; Snoddy HD; Perry KW
Res Commun Chem Pathol Pharmacol; 1986 Jan; 51(1):37-45. PubMed ID: 2419952
[TBL] [Abstract][Full Text] [Related]
7. The effect of noradrenergic receptor blocking agents on 5-hydroxytryptamine turnover in the brain of rats.
Zebrowska-Lupina I
Pol J Pharmacol Pharm; 1976; 28(4):341-7. PubMed ID: 135973
[TBL] [Abstract][Full Text] [Related]
8. Quipazine-metoclopramide inhibition of CB-154-induced prolactin suppression in rats: neurotransmitter-metabolite correlations.
Lipham LB; Porter JK; Norred WP; Booth NH; Robbins JD
Proc Soc Exp Biol Med; 1987 Mar; 184(3):250-5. PubMed ID: 2881309
[TBL] [Abstract][Full Text] [Related]
9. Quipazine induced wet dog shake behaviour in rats: mechanism of action.
Hiremagalur ; Keshavan JH; Dandiya PC; Gurbani NK
Pharmacol Res Commun; 1980 Sep; 12(8):757-68. PubMed ID: 6160597
[No Abstract] [Full Text] [Related]
10. Pharmacological evidence for a role of brain serotonin in the maintenance of plasma renin activity in unanesthetized rats.
Van de Kar LD; Wilkinson CW; Ganong WF
J Pharmacol Exp Ther; 1981 Oct; 219(1):85-90. PubMed ID: 6457138
[TBL] [Abstract][Full Text] [Related]
11. Quipazine: its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour.
Green AR; Youdim MB; Grahame-Smith DG
Neuropharmacology; 1976 Mar; 15(3):173-9. PubMed ID: 132619
[No Abstract] [Full Text] [Related]
12. Comparative effects of p-chloroamphetamine and 1-(p-chlorophenyl)piperazine on 5-hydroxyindole concentration in rat brain.
Fuller RW; Snoddy HD
Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):201-4. PubMed ID: 6157183
[TBL] [Abstract][Full Text] [Related]
13. Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
Lipham LB; Booth NH; Jernigan AD; Robbins JD; Hatch RC
Am J Vet Res; 1986 May; 47(5):1089-91. PubMed ID: 3717731
[TBL] [Abstract][Full Text] [Related]
14. Effects of N-cyclopropyl-4-chloroamphetamine on brain serotonin metabolism in rats.
Fuller RW; Molloy BB
Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):407-18. PubMed ID: 4750092
[No Abstract] [Full Text] [Related]
15. Mechanisms by which quipazine, a putative serotonin receptor agonist, alters brain 5-hydroxyindole metabolism.
Jacoby JH; Howd RA; Levin MS; Wurtman RJ
Neuropharmacology; 1976 Sep; 15(9):529-34. PubMed ID: 980228
[No Abstract] [Full Text] [Related]
16. The effects of quipazine on 5-HT metabolism in the rat brain.
Hamon M; Bourgoin S; Enjalbert A; Bockaert J; Hery F; Ternaux JP; Glowinski J
Naunyn Schmiedebergs Arch Pharmacol; 1976 Jul; 294(1):99-108. PubMed ID: 1004632
[TBL] [Abstract][Full Text] [Related]
17. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.
Mignon L; Wolf WA
Psychopharmacology (Berl); 2002 Aug; 163(1):85-94. PubMed ID: 12185404
[TBL] [Abstract][Full Text] [Related]
18. [Excellence of quipazine in the characterization of serotoninergic receptors and mechanisms].
Hong E
Gac Med Mex; 1982 Apr; 118(4):158-64. PubMed ID: 7117731
[No Abstract] [Full Text] [Related]
19. Disposition and pharmacological effects of m-Chlorophenylpiperazine in rats.
Fuller RW; Snoddy HD; Mason NR; Owen JE
Neuropharmacology; 1981 Feb; 20(2):155-62. PubMed ID: 6163105
[No Abstract] [Full Text] [Related]
20. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
Rokosz-Pelc A; Antkiewicz-Michaluk L; Vetulani J
J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
[No Abstract] [Full Text] [Related]
[Next] [New Search]
